Important note

This AI stock analysis for Amarin is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!

Amarin - AI Stock Analysis

Analysis generated October 29, 2024

Amarin Corporation plc (NASDAQ: AMRN) is a biopharmaceutical company known for its flagship product, Vascepa (icosapent ethyl), which is derived from fish oil and used to lower triglycerides in adults with severe hypertriglyceridemia. The company focuses primarily on improving cardiovascular health and advancing the management of cardiovascular disease. Headquartered in Dublin, Ireland, Amarin's mission is to leverage drug research and technology to reduce the burden of cardiovascular disease globally.

Fundamental Analysis

Amarin's revenue for the last quarter was $68 million, representing a 19.32% increase compared to the previous quarter. This is a positive indicator of growth and suggests that the company’s strategies to boost its sales are paying off. However, it is important to note that compared to the same quarter last year, revenue decreased by 15.76%, which could indicate underlying issues or increased competition in the market.

Net income for the last quarter was $1.5 million, an impressive increase of 115.29% compared to the previous quarter. When evaluated year-over-year, this figure increased by 108.67%, reflecting significant growth and improvement in profitability. The growth in net income amidst challenging market conditions underscores Amarin's strong financial management and operational efficiency.

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) for the last quarter was $210,000. This indicates a 101.59% increase compared to the previous quarter and a 100.88% increase year-over-year. The growing EBITDA signals that Amarin is effectively controlling its operating expenses while increasing its overall earnings power.

Technical Analysis

Today’s stock price for Amarin stands at $0.61. This represents a 1.67% increase compared to a month ago, indicating a positive short-term trend. However, the stock price is down by 11.59% compared to a year ago, which could be a cause for concern over the long term.

The stock's current trend is bullish, supported by a Simple Moving Average (SMA10) of 0.59, which is higher than the previous SMA10 of 0.59. This suggests a potential upward trend in price movement. The Relative Strength Index (RSI) is at 52, indicating a neutral condition — the stock is neither overbought nor oversold.

Alternative Data Analysis

From a job postings and employee sentiment perspective, Amarin currently has 2 open positions according to data from popular job boards. This is a 100% increase in job openings over the last couple of months, signaling potential company growth and expansion, which is a healthy sign.

Examining customer acquisition data, Amarin has around 6,000 visitors to their webpage with no significant change in recent months. Similarly, in terms of customer engagement, Amarin has 2,200 followers on their Twitter page, with no considerable fluctuations recently. These steady figures could indicate a stable customer base but also suggest no significant growth in awareness or engagement.

An important metric to consider is AltIndex’s AI score, which endeavors to predict a company's stock price based on fundamental, technical, and alternative data analyses. Amarin has an AI score of 41, which translates to a 'Hold' signal. It reflects a current evaluation suggesting that the stock is relatively stable with moderate growth potential.

Conclusion and Recommendation

Amarin Corporation shows promising signs of short-term growth with increasing revenue and profitability as indicated by its fundamental metrics. The bullish trend in stock price supported by technical indicators like SMA and RSI also indicates a potential upward trajectory. However, the year-over-year decline in revenue and stock price, coupled with stagnant customer engagement figures, raises some concerns about the company's long-term growth prospects.

Given the mixed signals from different analysis perspectives and an AI score of 41 suggesting a 'Hold', it would be prudent for investors to maintain their current position in Amarin. Continuous monitoring of their financials and market position is recommended before making any decisive moves.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.